Russia's coronavirus vaccine Sputnik-V will be trialled in India by Dr. Reddy's Laboratory Limited, a global pharmaceutical company, Dr. Reddy's Laboratory Limited. It has been agreed between the Russian Direct Investment Fund (RDIF) and Dr. Reddy's Laboratories (DRL). Only Dr. Reddy's Laboratories Ltd. will conduct clinical trials and distribution of Russia's Corona vaccine. After receiving regulatory approval, RDIF will give 100 million doses of vaccine to DRL.
The delivery of the vaccine can begin by the end of 2020, after the trial is successful and the person registrations from the Indian Authority. Clinical trial of this much talked about vaccine of Russia is going on.
Let me tell you that just last week, the member of NITI Aayog, Dr. VK Paul had told in a press conference that Russia has requested to trial its vaccine in India. 3-4 companies have also responded to this. He described it as a win-win situation for all.
Earlier (RDIF) Chief Executive Officer (CEO) Kirill Dimitrev also said that Russia would start a clinical trial of its vaccine in India from this month. He had told that there are plans to do a clinical trial in September, in Saudi Arabia, United Arab Emirates, Philippines, India and Brazil.
Read also: Aurobindo Pharma and CSIR come together for COVID-19 vaccine, preparations start for manufacturing
Let us know that Russia had announced to become its own vaccine last month. While announcing this, Russian President Vladimir Putin also said that the first dose has been given to his daughter and she is feeling good. Russia has named this vaccine after one of its satellites. Russia has claimed that this vaccine will develop a permanent immunity against Kovid-19 in the body. At the same time, at the beginning of the month there was a research report in Lancet, which said that the vaccine was found to be safe on patients in the initial test and they had developed antibodies without any reaction or reversal.
Video: Lancet study claims, 'Russia's coronavirus vaccine is safe'